Organoids, miniaturized, stem cell-derived versions of human organs, are revolutionizing biomedical research by offering human-specific models for disease study and drug testing. While they have ...

Numerous studies have suggested the cultivation of cells derived from intestinal organoids as two-dimensional (2D) monolayers ...

“This is a clear and deliberate shift,” Corbett says.

Agilent Technologies Inc. (NYSE: A) today announced release of the new Seahorse XF Flex Analyzer, a high-performance, 24-well ...

One in three Americans is likely to be affected by a brain disorder in their lifetime. Many of these conditions, such as ...

Here’s a look at some of the most recent discoveries from UCLA scientists that are helping to advance more effective and targeted treatment strategies for glioblastoma and other aggressive brain ...

Auron Therapeutics, a clinical-stage biotechnology company targeting cell-state plasticity to improve patient outcomes in oncology and inflammatory disease, today announced preclinical data in ...

Using a series of experiments, Auron demonstrated activity with AUTX-703, its oral, potent and selective degrader targeting KAT2A/B in cell lines and patient derived organoid models (PDXO ...

Researchers can realize significant benefits with the BMN models including: The introduction of the BMN platform seamlessly integrates into Crown Bioscience’s expertise in 3D organoid-like cell ...